Skip to content

Company

Atea Pharmaceuticals

AVIR · United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Atea Pharmaceuticals?

Held by 44 covered funds. Sorted by Atea Pharmaceuticals’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
SBIOALPS Medical Breakthroughs0.2%
IWCiShares Micro-Cap0.1%
NOSGXSmall Cap Value Fund0.1%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
AVSCAvantis U.S. Small Cap Equity0.0%
AVSCXAvantis U.S. Small Cap Equity Fund0.0%
IBBiShares Biotechnology0.0%
IWNiShares Russell 2000 Value0.0%
VTWVVanguard Russell 2000 Value Index Fund0.0%
OMFSInvesco Russell 2000 Dynamic Multifactor0.0%
PKWInvesco Buyback Achievers0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
RSSLGlobal X Russell 20000.0%
IWMiShares Russell 20000.0%
NSIDXSmall Cap Index Fund0.0%
VTWOVanguard Russell 2000 Index Fund0.0%
ITWOProShares Russell 2000 High Income0.0%
DFASDimensional U.S. Small Cap0.0%
SCHASchwab U.S. Small-Cap0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
FESMFidelity Enhanced Small Cap Core0.0%
VXFVanguard Extended Market Index Fund0.0%
VHTVanguard Health Care Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
ONEQFidelity Nasdaq Composite Index0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
DCORDimensional US Core Equity 10.0%
AVUNXAvantis U.S. Equity Fund0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
DFACDimensional U.S. Core Equity 20.0%
DFAUDimensional US Core Equity Market0.0%
SCHBSchwab U.S. Broad Market0.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
SSBIXState Street Balanced Index Fund0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
AVUSAvantis U.S. Equity0.0%
IWViShares Russell 30000.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
DFQTXU.S. Core Equity 2 Portfolio0.0%
DFUSDimensional U.S. Equity Market0.0%
DXUVDimensional US Vector Equity0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Atea Pharmaceuticals news

No recent stories about Atea Pharmaceuticals.